NZ520927A - Orally administered controlled delivery system for once daily administration of ciprofloxacin - Google Patents
Orally administered controlled delivery system for once daily administration of ciprofloxacinInfo
- Publication number
- NZ520927A NZ520927A NZ520927A NZ52092701A NZ520927A NZ 520927 A NZ520927 A NZ 520927A NZ 520927 A NZ520927 A NZ 520927A NZ 52092701 A NZ52092701 A NZ 52092701A NZ 520927 A NZ520927 A NZ 520927A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ciprofloxacin
- orally administered
- delivery system
- once daily
- daily administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A sustained release solid dosage form of ciprofloxacin that when orally administered under fed conditions, provides properties of mean peak serum/plasma concentration, area under the serum/plasma concentration-time curve above the minimum inhibitory concentrations, durations above minimum inhibitory serum/plasma concentrations, of at least 70% that of divided does immediate release ciprofloxacin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51788700A | 2000-03-03 | 2000-03-03 | |
| PCT/IB2001/000279 WO2001064183A1 (en) | 2000-03-03 | 2001-02-28 | Orally administered controlled delivery system for once daily administration of ciprofloxacin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ520927A true NZ520927A (en) | 2003-06-30 |
Family
ID=24061635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ520927A NZ520927A (en) | 2000-03-03 | 2001-02-28 | Orally administered controlled delivery system for once daily administration of ciprofloxacin |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1263409A1 (en) |
| JP (1) | JP2003525229A (en) |
| KR (1) | KR20030009374A (en) |
| CN (1) | CN1420763A (en) |
| AP (2) | AP2001002084A0 (en) |
| AR (1) | AR032614A1 (en) |
| AU (1) | AU3589701A (en) |
| BG (1) | BG107055A (en) |
| BR (1) | BR0108958A (en) |
| CA (1) | CA2400950A1 (en) |
| CZ (1) | CZ20022883A3 (en) |
| DO (1) | DOP2001000130A (en) |
| EA (1) | EA200200914A1 (en) |
| EC (1) | ECSP013952A (en) |
| EE (1) | EE200200497A (en) |
| GT (1) | GT200100033A (en) |
| HN (1) | HN2001000038A (en) |
| HR (1) | HRP20020715A2 (en) |
| HU (1) | HUP0204417A3 (en) |
| IL (1) | IL151553A0 (en) |
| IS (1) | IS6532A (en) |
| MX (1) | MXPA02008568A (en) |
| NO (1) | NO20024108L (en) |
| NZ (1) | NZ520927A (en) |
| OA (1) | OA12381A (en) |
| PE (1) | PE20011113A1 (en) |
| PL (1) | PL365071A1 (en) |
| SK (1) | SK12542002A3 (en) |
| WO (1) | WO2001064183A1 (en) |
| YU (1) | YU66202A (en) |
| ZA (1) | ZA200206764B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
| DE10351448A1 (en) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Flavor-containing drug formulations with improved pharmaceutical properties |
| EP1745775B1 (en) | 2005-07-19 | 2008-05-28 | Ethypharm | Gastroretentive formulations and manufacturing process thereof. |
| DE602006012962D1 (en) * | 2006-07-19 | 2010-04-29 | Tabuk Pharmaceutical Mfg Co | Pharmaceutical preparations of ciprofloxacin |
| EP3247384B1 (en) | 2015-01-14 | 2023-10-04 | The Regents of the University of Colorado, a body corporate | In vitro method of diagnosis of type 1 diabetes with insulin mimotopes |
| CA3015400A1 (en) * | 2016-02-23 | 2017-08-31 | Matripharm International Inc. | Dual-rate release formulation with high drug loading |
| AU2017236977B2 (en) | 2016-03-24 | 2022-05-26 | Immunomolecular Therapeutics, Inc. | Methods of treating autoimmune disease |
| US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
| US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
| CN109806237A (en) * | 2019-03-13 | 2019-05-28 | 悦康药业集团上海制药有限公司 | A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| JPH0624959A (en) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | Medice release solid pharmaceutical preparation of gastric suspending type sustained |
| DE4406424A1 (en) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandable dosage forms |
| DE19839057A1 (en) * | 1998-08-28 | 2000-03-02 | Koch Berthold | Purge air controller for a drying device for compressed air |
| NZ510487A (en) * | 1998-09-14 | 2003-04-29 | Ranbaxy Lab Ltd | Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form |
-
2001
- 2001-02-28 PL PL01365071A patent/PL365071A1/en not_active Application Discontinuation
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/en unknown
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 EE EEP200200497A patent/EE200200497A/en unknown
- 2001-02-28 NZ NZ520927A patent/NZ520927A/en unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/en active Pending
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/en unknown
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/en not_active Withdrawn
- 2001-02-28 IL IL15155301A patent/IL151553A0/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/en unknown
- 2001-02-28 YU YU66202A patent/YU66202A/en unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/en unknown
- 2001-02-28 AR ARP010100957A patent/AR032614A1/en not_active Application Discontinuation
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/en not_active Withdrawn
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/en unknown
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/en not_active Application Discontinuation
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-03-01 GT GT200100033A patent/GT200100033A/en unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/en not_active Application Discontinuation
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/en unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/en unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/en unknown
-
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/en unknown
- 2002-08-30 HR HRP20020715 patent/HRP20020715A2/en not_active Application Discontinuation
- 2002-09-02 BG BG107055A patent/BG107055A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1263409A1 (en) | 2002-12-11 |
| BG107055A (en) | 2003-06-30 |
| HUP0204417A3 (en) | 2005-03-29 |
| DOP2001000130A (en) | 2004-03-31 |
| KR20030009374A (en) | 2003-01-29 |
| YU66202A (en) | 2005-09-19 |
| EA200200914A1 (en) | 2003-02-27 |
| AP2002002627A0 (en) | 2002-09-30 |
| GT200100033A (en) | 2001-10-25 |
| HUP0204417A2 (en) | 2003-05-28 |
| AR032614A1 (en) | 2003-11-19 |
| CZ20022883A3 (en) | 2003-04-16 |
| IS6532A (en) | 2002-08-28 |
| CN1420763A (en) | 2003-05-28 |
| JP2003525229A (en) | 2003-08-26 |
| ECSP013952A (en) | 2002-04-23 |
| PL365071A1 (en) | 2004-12-27 |
| NO20024108D0 (en) | 2002-08-28 |
| EE200200497A (en) | 2004-02-16 |
| CA2400950A1 (en) | 2001-09-07 |
| WO2001064183A1 (en) | 2001-09-07 |
| NO20024108L (en) | 2002-10-25 |
| AU3589701A (en) | 2001-09-12 |
| HRP20020715A2 (en) | 2004-12-31 |
| PE20011113A1 (en) | 2001-10-14 |
| ZA200206764B (en) | 2003-03-04 |
| IL151553A0 (en) | 2003-04-10 |
| HN2001000038A (en) | 2005-03-23 |
| SK12542002A3 (en) | 2003-05-02 |
| BR0108958A (en) | 2003-09-30 |
| AP1485A (en) | 2005-10-31 |
| AP2001002084A0 (en) | 2001-03-31 |
| MXPA02008568A (en) | 2003-02-24 |
| OA12381A (en) | 2004-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
| NZ514574A (en) | Novel method of treatment | |
| HRP20050077B1 (en) | Methods and dosage forms for controlled delivery of paliperidone | |
| MX2009004861A (en) | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor. | |
| AU2003297048A1 (en) | Cyclohexyl compounds as ccr5 antagonists | |
| BG105857A (en) | Pregelatinized starch in a controlled release formulation | |
| IL172082A0 (en) | Foamable pharmaceutical compositions and methods for treating a disorder | |
| UA88270C2 (en) | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes | |
| AU2003296992A1 (en) | Pyrrolidine and azetidine compounds as ccr5 antagonists | |
| NZ520927A (en) | Orally administered controlled delivery system for once daily administration of ciprofloxacin | |
| ZA94413B (en) | Pharmaceutical formulation for the treatment of nicotine dependence | |
| IL165786A0 (en) | Ibuprofen suspension | |
| AU2003300911A1 (en) | Heterocyclic compounds as ccr5 antagonists | |
| MY144021A (en) | Pharmaceutical delivery system | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| ES2130081B1 (en) | TRIMEBUTINE MALEATE TABLET WITH LAMINAR COATING. | |
| EP1256344A4 (en) | Remedies for endothelin-induced diseases | |
| IL143985A0 (en) | New use of melagatran | |
| MXPA04001805A (en) | A new extended release oral dosage form. | |
| AU3278800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
| DE69803670D1 (en) | MEDICINE PREPARATIONS WITH TIAGABINE WITH CONTROLLED ACTIVE SUBSTANCE ADMINISTRATION | |
| AU2907800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism | |
| AU5981200A (en) | Transdermal therapeutic system for administering a calcium antagonist | |
| WO2004050019A3 (en) | Method and compositions for treating anxiety | |
| BG104064A (en) | Medicamentous form with controlled release of poorly soluble basic medicamentous forms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |